Soejima Yutaro, Kirino Yohei, Takeno Mitsuhiro, Kurosawa Michiko, Takeuchi Masaki, Yoshimi Ryusuke, Sugiyama Yumiko, Ohno Shigeru, Asami Yukiko, Sekiguchi Akiko, Igarashi Toshihisa, Nagaoka Shohei, Ishigatsubo Yoshiaki, Nakajima Hideaki, Mizuki Nobuhisa
Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Department of Allergy and Rheumatology, Nippon Medical School, Musashi Kosugi Hospital, 1-396 Kosugi-machi, Nakahara-ku, Kawasaki, Kanagawa, 211-8533, Japan.
Arthritis Res Ther. 2021 Feb 1;23(1):49. doi: 10.1186/s13075-020-02406-6.
We hypothesized that Behçet's disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD.
A total of 657 patients registered in the Yokohama City University (YCU) regional BD registry between 1990 and 2018, as well as 6754 patients who were initially registered in the Japanese Ministry of Health, Labour and Welfare (MHLW) database between 2003 and 2014, were investigated. The YCU registry data regarding the clinical manifestations of BD, human leukocyte antigen (HLA) status, treatments, and hospitalizations were analyzed first, followed by similar analyses of the MHLW for validation. A hierarchical cluster analysis was independently performed in both patient groups.
A hierarchical cluster analysis determined five independent clinical clusters in the YCU cohort. Individual counterparts of the YCU clusters were confirmed in the MHLW registry. Recent phenotypical evolutions of BD in Japan, such as increased gastrointestinal (GI) involvement, reduced complete type according to the Japan Criteria, and reduced HLA-B51 positivity were associated with chronologically changing proportions of the clinical clusters.
In this study, we identified independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. We propose five independent clusters namely "mucocutaneous", "mucocutaneous with arthritis", "neuro", "GI", and "eye."
我们推测白塞病(BD)由几种严重程度不同的临床亚型组成,导致该疾病具有异质性。在此,我们开展了一项研究以识别BD的临床聚类。
对1990年至2018年间登记在横滨市立大学(YCU)地区BD登记处的657例患者,以及2003年至2014年间最初登记在日本厚生劳动省(MHLW)数据库中的6754例患者进行了调查。首先分析了YCU登记处有关BD临床表现、人类白细胞抗原(HLA)状态、治疗及住院情况的数据,随后对MHLW的数据进行了类似分析以作验证。在两组患者中分别独立进行了分层聚类分析。
分层聚类分析在YCU队列中确定了五个独立的临床聚类。YCU聚类的个体对应情况在MHLW登记处得到了证实。日本BD近期的表型演变,如胃肠道(GI)受累增加、根据日本标准的完全型减少以及HLA - B51阳性率降低,与临床聚类随时间变化的比例相关。
在本研究中,我们在日本的BD患者中识别出了独立的临床聚类,并发现每个聚类的比例随时间而变化。我们提出了五个独立的聚类,即“黏膜皮肤型”、“黏膜皮肤伴关节炎型”、“神经型”、“胃肠道型”和“眼型”。